Skip to main content

Notable Downgrades: Mirati Therapeutics (MRTX), Juniper (JNPR), Cloud Peak Energy (CLD), Paylocity Holding (PCTY)

Mirati Therapeutics, Inc. (MRTX) was downgraded by Brean Capital from a ‘Buy‘ rating to a ‘Hold‘ rating in a research report issued to clients on Monday. MRTX closed at $36.66 on Friday and is currently trading down $9.16. Over the past year, shares of San Diego, Calif.-based clinical stage biopharmaceutical company have traded between a […] View the full post at: Notable Downgrades: Mirati Therapeutics (MRTX), Juniper (JNPR), Cloud Peak Energy (CLD), Paylocity Holding (PCTY) Related posts: Microsoft Loses Top Executive To Juniper Warren Buffett’s Holding Company Reduces Stake in Moody’s Shares After-Hours Earnings (April 20)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.